TFC Financial Management’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,800
Closed -$320K 920
2023
Q4
$320K Sell
10,800
-7,150
-40% -$142K 0.06% 84
2023
Q3
$285K Hold
17,950
0.07% 86
2023
Q2
$339K Hold
17,950
0.08% 76
2023
Q1
$68.9K Hold
17,950
0.02% 198
2022
Q4
$89K Hold
17,950
0.03% 168
2022
Q3
$86K Hold
17,950
0.03% 164
2022
Q2
$81K Hold
17,950
0.02% 170
2022
Q1
$85K Buy
17,950
+2,750
+18% +$15.2K 0.02% 172
2021
Q4
$113K Hold
15,200
0.03% 155
2021
Q3
$86K Hold
15,200
0.03% 175
2021
Q2
$100K Hold
15,200
0.03% 158
2021
Q1
$123K Hold
15,200
0.05% 126
2020
Q4
$98K Hold
15,200
0.04% 143
2020
Q3
$55K Buy
+15,200
New +$61.4K 0.03% 171

Other funds holding IMGN

TFC Financial Management's IMGN Position: Q1 2024 in Review

TFC Financial Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 10,800 shares — an estimated $320K sold.

TFC Financial Management first reported a position in IMGN in Q3 2020 and held it in 14 quarters. The position peaked at $339K in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • TFC Financial Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • TFC Financial Management sold 10,800 Immunogen Inc shares in Q1 2024, an estimated $320K.
  • TFC Financial Management first reported a position in Immunogen Inc in Q3 2020 and held it in 14 quarters.
  • TFC Financial Management's Immunogen Inc position peaked at $339K in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on TFC Financial Management's 13F filing for Q1 2024, filed 30 Apr 2024.